Ameriflex Group Inc. bought a new position in The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 11,127 shares of the company's stock, valued at approximately $1,847,000. Procter & Gamble makes up approximately 0.8% of Ameriflex Group Inc.'s investment portfolio, making the stock its 22nd biggest holding.
Several other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC grew its holdings in shares of Procter & Gamble by 933.3% during the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after purchasing an additional 140 shares during the last quarter. Navigoe LLC bought a new position in shares of Procter & Gamble during the 4th quarter valued at $31,000. Hoey Investments Inc. grew its holdings in shares of Procter & Gamble by 321.7% during the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after purchasing an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in shares of Procter & Gamble during the 4th quarter valued at $34,000. Finally, 10Elms LLP bought a new position in shares of Procter & Gamble during the 4th quarter valued at $34,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Trading Down 0.3%
Shares of PG stock traded down $0.43 during trading hours on Wednesday, hitting $167.33. The company had a trading volume of 5,367,489 shares, compared to its average volume of 7,287,524. The company's fifty day moving average is $164.14 and its 200 day moving average is $167.35. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43. The stock has a market capitalization of $392.31 billion, a PE ratio of 26.64, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period in the prior year, the firm earned $1.52 EPS. The firm's revenue for the quarter was down 2.1% on a year-over-year basis. Research analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were issued a $1.0568 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date was Monday, April 21st. This represents a $4.23 annualized dividend and a dividend yield of 2.53%. Procter & Gamble's dividend payout ratio is presently 66.98%.
Insider Activity
In related news, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction on Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the sale, the insider now owns 25,182 shares in the company, valued at $3,995,627.94. This represents a 29.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the sale, the chief executive officer now owns 22,051 shares of the company's stock, valued at approximately $3,829,817.68. This represents a 61.35% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 46,520 shares of company stock worth $7,909,388. Corporate insiders own 0.18% of the company's stock.
Wall Street Analyst Weigh In
PG has been the topic of a number of recent analyst reports. Redburn Atlantic lowered shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a report on Thursday, May 1st. Royal Bank of Canada raised shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and raised their price target for the stock from $164.00 to $177.00 in a report on Friday, April 25th. Redburn Partners set a $161.00 price target on shares of Procter & Gamble in a research report on Thursday, May 1st. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Finally, Morgan Stanley set a $180.00 price objective on Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $178.52.
Check Out Our Latest Analysis on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.